MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Early diagnosis of progressive supranuclear palsy using quantitative MRI analysis of brain structure

K. Seo, T. Yamamoto, H. Kawasaki, T. Hukuoka, Y. Nakazato, K. Takahashi, I. Matunari, H. Matuda, N. Tamura, N. Araki (Saitama, Japan)

Meeting: 2019 International Congress

Abstract Number: 1069

Keywords: Progressive supranuclear palsy(PSP)

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: We examined whetherquantitative MRI analysis of brain structure was useful for early diagnosis of PSP.

Background: Quantitative analysis of brain structure by means of MRI in patients with progressive supranuclear palsy (PSP) has showed that distribution of atrophy was useful for distinguishing PSP from Parkinson’s disease (PD). However, there has not been reported on the quantitative brain MRI analysis in an early stage of PSP patients.

Method: Six patients with clinically diagnosed PSP including predominant cerebellarataxia (C)andprogressive gait freezing (PGF), 3 cases of predominant parkinsonism (P). All cases were difficult to discriminate from PD in the early clinical stage. One case of Richardson’s syndrome (RS)and 4case of PDthat were able to be observed for a long time, were used as control.Brain segmentation and volumetric measurement by Free Surfer were performed on brain MRI images which were taken repeatedly with the clinical course.Z-score of each region was calculated in each case using analysis data of 536 healthy groups, and it was used to evaluate the brain structural changes.

Results: PSP group showed atrophy of the globus pallidus, thalamus and midbrain and enlargement of the third ventricle at the time of the first visit (within 0.8 to 2 years since onset) and those changes were proceeded with the clinical course.In PD group, structural change was not observed during the clinical course regarding the difference from the PSP group.

Conclusion: Quantitative MRI analysis of the brain structure detected a brain structure change in PSP group was different from that of PD group in the early onset before clinical diagnosis of PSP was confirmed (5 to 9 years after onset), suggesting that quantitative MRI analysis of brain structure is useful as an imaging biomarker for early diagnosis of PSP.

To cite this abstract in AMA style:

K. Seo, T. Yamamoto, H. Kawasaki, T. Hukuoka, Y. Nakazato, K. Takahashi, I. Matunari, H. Matuda, N. Tamura, N. Araki. Early diagnosis of progressive supranuclear palsy using quantitative MRI analysis of brain structure [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/early-diagnosis-of-progressive-supranuclear-palsy-using-quantitative-mri-analysis-of-brain-structure/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/early-diagnosis-of-progressive-supranuclear-palsy-using-quantitative-mri-analysis-of-brain-structure/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley